Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2019

Nov 14, 2019

30071_dirs_2019-11-13_c9896fec-8aff-4435-8e59-9d89b52e98f4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-11-11

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-11 ResMed Common Stock M 6651 $43.63 Acquired 320067 Direct
2019-11-11 ResMed Common Stock S 3573 $143.477 Disposed 316494 Direct
2019-11-11 ResMed Common Stock S 3070 $144.473 Disposed 313424 Direct
2019-11-11 ResMed Common Stock S 8 $145.17 Disposed 313416 Direct
2019-11-11 ResMed Common Stock F 3417 $143.88 Disposed 309999 Direct
2019-11-11 ResMed Common Stock F 2973 $143.88 Disposed 307026 Direct
2019-11-11 ResMed Common Stock F 4495 $143.88 Disposed 302531 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-11-11 ResMed Common Stock Options $43.63 M 6651 Disposed 2020-03-01 ResMed Commmon Stock (6651) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 10340 Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Includes 183.40 shares of ResMed stock purchased on October 31, 2019, through the ResMed Employee Stock Purchase Plan.

F3: This transaction was executed in multiple trades at prices ranging from $143.12 to 144.12. The price reported above reflects the weighted average sale price.

F4: This transaction was executed in multiple trades at prices ranging from $144.13 to $145.02. The price reported above reflects the weighted average sale price.

F5: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.

F6: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018.

F7: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.

F8: Represents date options first became exercisable. Options vest 1/3 per year.